Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users

International Journal of Drug Policy

Volumn 26, Issue 1, 2015, Pages 78-83

  Uosukainen, Hanna ^a   Tacke, Ulrich ^a,b   Winstock, Adam R ^c,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d Global Drug Survey   (United Kingdom)

Author keywords

Cocaine; Ketamine; MDMA; Mephedrone; Substance related disorders

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; COCAINE; KETAMINE; METHAMPHETAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE; DRUG USE; DSM-IV; FEMALE; HUMAN; INTERNET; MALE; PREVALENCE; RECREATIONAL POLYDRUG USER; SELF REPORT; SYMPTOM; UNITED KINGDOM; ADOLESCENT; ANALOGS AND DERIVATIVES; COCAINE-RELATED DISORDERS; COMPARATIVE STUDY; DRUG ABUSE; INFORMATION PROCESSING; STATISTICAL MODEL; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; HUMANS; KETAMINE; LOGISTIC MODELS; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREVALENCE; SELF REPORT; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84919846558     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2014.07.004     Document Type: Article

References (49)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington DC.
2. American Psychiatric Association DSM-V development 2013, Retrieved from. http://www.dsm5.org/.
3. Boeri M., Sterk C., Bahora M., Elifson K. Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns. Journal of Drug Issues 2008, 38:517-541.
4. Bruno R., Matthews A.J., Topp L., Degenhardt L., Gomez R., Dunn M. Can the severity of dependence scale be usefully applied to 'ecstasy'?. Neuropsychobiology 2009, 60:137-147.
5. Brunt T.M., Poortman A., Niesink R.J., van den Brink W. Instability of the ecstasy market and a new kid on the block: Mephedrone. Journal of Psychopharmacology 2011, 25:1543-1547.
6. Cottler L.B., Leung K.S., Abdallah A.B. Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: A cross-national study. Addiction 2009, 104:1679-1690.
7. Cottler L.B., Womack S.B., Compton W.M., Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: Applicability and reliability of DSM-IV criteria. Human Psychopharmacology 2001, 16:599-606.
8. Dackis C.A., Gold M.S. New concepts in cocaine addiction: The dopamine depletion hypothesis. Neuroscience and Biobehavioral Reviews 1985, 9:469-477.
9. de Almeida S.P., Garcia-Mijares M., Silva M.T. Patterns of ecstasy use and associated harm: Results of a Brazilian online survey. Substance Use and Misuse 2009, 44:2014-2027.
10. Degenhardt L., Bruno R., Topp L. Is ecstasy a drug of dependence?. Drug and Alcohol Dependence 2010, 107:1-10.
11. Degenhardt L., Copeland J., Dillon P. Recent trends in the use of "club drugs": An Australian review. Substance Use and Misuse 2005, 40:1241-1256.
12. Degenhardt L., Dunn M. The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy 2008, 19:311-316.
13. De Luca M.T., Meringolo M., Spagnolo P.A., Badiani A. The role of setting for ketamine abuse: Clinical and preclinical evidence. Reviews in the Neurosciences 2012, 23:769-780.
14. European Monitoring Centre for Drugs and Drug Addiction Annual report 2011, The State of the Drugs Problem in Europe 2011, Publications Office of the European Union, Luxembourg.
15. European Monitoring Centre for Drugs and Drug Addiction Annual report 2012, The state of drugs problem in Europe 2012, Publications Office of the European Union, Luxembourg.
16. Fantegrossi W.E. In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys. Experimental and Clinical Psychopharmacology 2008, 16:1-12.
17. Gawin F.H. Cocaine addiction: Psychology and neurophysiology. Science 1991, 251:1580-1586.
18. Hadlock G.C., Webb K.M., McFadden L.M., Chu P.W., Ellis J.D., Allen S.C., et al. 4 Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse. The Journal Pharmacology and Experimental Therapeutics 2011, 339:530-536.
19. Home Office Statistics Drugs misuse declared: Findings from the 2011/12 Crime Survey for England and Wales 2012, 2nd edition.
20. IBM Corporation IBM SPSS Advanced Statistics 21 2012, Retrieved from. ftp://public.dhe.ibm.com/software/analytics/spss/documentation/statistics/21.0/en/client/Manuals/IBM_SPSS_Advanced_Statistics.pdf.
21. Jansen K.L., Darracot-Cankovic R. The nonmedical use of ketamine, part two: A review of problem use and dependence. Journal of Psychoactive Drugs 2001, 33:151-158.
22. Kalsi S.S., Wood D.M., Dargan P.I. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerging Health Threats Journal 2011, 4:7107.
23. Knapp W.P., Soares B.G., Farrel M., Lima M.S. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Systematic Reviews 2007, 3:CD003023.
24. Koob L., Le Moal M. Psychostimulants. Neurobiology of addiction 2006, 69-120. Academic Press, Elsevier Inc. L. Koob, M. Le Moal (Eds.).
25. Lankenau S.E., Clatts M.C. Patterns of polydrug use among ketamine injectors in New York City. Substance Use and Misuse 2005, 40:1381-1397.
26. Lopez-Quintero C., Perez de los Cobos J., Hasin D.S., Okuda M., Wang S., Grant B.F., et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence 2011, 115:120-130.
27. Marsden J., Eastwood B., Bradbury C., Dale-Perera A., Farrell M., Hammond P., et al. Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study. Lancet 2009, 374:1262-1270.
28. McCambridge J., Mitcheson L., Winstock A., Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 2005, 100:1140-1149.
29. Nutt D.J., King L.A., Phillips L.D., Independent Scientific Committee on Drugs Drug harms in the UK: A multicriteria decision analysis. Lancet 2010, 376:1558-1565.
30. O'Brien M.S., Anthony J.C. Risk of becoming cocaine dependent: Epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005, 30:1006-1018.
31. Schuckit M.A., Saunders J.B. The empirical basis of substance use disorders diagnosis: Research recommendations for the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V). Addiction 2006, 101:S170-S173.
32. Shorter D., Kosten T.R. Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine 2011, 9:119.
33. Sindicich N., Burns L. Australian trends in ecstasy and related drug markets 2012: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No. 100 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
34. Smart R.G., Ogborne A.C. Drug use and drinking among students in 36 countries. Addictive Behaviours 2000, 25:455-460.
35. Smith K., Flatley J. Drug Misuse Declared: Findings from the 2010/11 British Crime Survey. Home Office Statistics 2011, Home Office Statistical Bulletin, London.
36. Stone A.L., O'Brien M.S., De La Torre A., Anthony J.C. Who is becoming hallucinogen dependent soon after hallucinogen use starts?. Drug and Alcohol Dependence 2007, 87:153-163.
37. Topp L., Barker B., Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 2004, 73:33-40.
38. United Nations Office on Drugs and Crime World Drug Report 2012 2012, 1. United Nations Publication, Sales No. E.12.XI.
39. von Sydow K., Lieb R., Pfister H., Höfler M., Wittchen H.U. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-A transient phenomenon?. Results from a longitudinal community study. Drug and Alcohol Dependence 2002, 66:147-159.
40. Winstock A.R., Barratt M.J. Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence 2013, 131:106-111.
41. Winstock A.R., Griffiths P., Stewart D. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence 2001, 64:9-17.
42. Winstock A.R., Marsden J. Mephedrone: Assessment of health risks and harms. Appendix 1 to Annex 1 (Technical report on mephedrone) 2010, EMCDDA contract CT.10.EPI.034. National Addiction Centre, Institute of Psychiatry, London, UK.
43. Winstock A.R., Mitcheson L.R., Deluca P., Davey Z., Corazza O., Schifano F. Mephedrone, new kid for the chop?. Addiction 2011, 106:154-161.
44. Winstock A.R., Mitcheson L., Marsden J. Mephedrone: Still available and twice the price. Lancet 2010, 376:1537.
45. Winstock A.R., Mitcheson L., Ramsey J., Davies S., Puchnarewicz M., Marsden J. Mephedrone: Use, subjective effects and health risks. Addiction 2011, 106:1991-1996.
46. Wood D.M., Dargan P.I. Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2012, 39:227-233.
47. Wood D.M., Davies S., Greene S.L., Button J., Holt D.W., Ramsey J., et al. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clinical Toxicology 2010, 48:924-927.
48. Wu L.T., Ringwalt C.L., Mannelli P., Patkar A.A. Hallucinogen use disorders among adult users of MDMA and other hallucinogens. American Journal of Addiction 2008, 17:354-363.
49. Yen C.F., Hsu S.Y. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents. The Journal of Nervous and Mental Disease 2007, 195:866-869.